Los Angeles, California
Alzheimer's medication trials in Los Angeles, CA
8 Alzheimer's medication studies are recruiting participants at sites in Los Angeles as of November 17, 2026, according to ClinicalTrials.gov. Alzheimer's Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Los Angeles at a glance
- 8 studies are recruiting at a site in Los Angeles.
- By phase: Phase 1 (1), Phase 2 (1), Phase 3 (6).
- By sponsor: industry (8).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in Los Angeles
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Inglewood Clinical
- Registry record
- NCT06976203 · updated
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
- Registry record
- NCT05980949 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Inglewood Clinicals
- Registry record
- NCT07717411 · updated
A Study of LY3439539 in Participants With Alzheimer's Disease
- Phase 1
- Ages 50 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Inglewood Clinical
- Registry record
- NCT07598370 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
- Registry record
- NCT06585787 · updated
[18F]PI-2620 Phase 3 Histopathological Study
- Phase 3
- Ages 50 and older
- All sexes
- Sponsor
- Lantheus Biosciences Ltd.
- Study site
- UC Los Angeles
- Registry record
- NCT05641688 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Inglewood Clinical ( Site 1062)
- Registry record
- NCT07033494 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine
- Registry record
- NCT06563895 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Los Angeles, CA on ClinicalTrials.gov.
Ask about studies near Los Angeles
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
38 studies recruiting across 31 cities.
Irvine
9 studies recruiting.
Anaheim
8 studies recruiting.
Long Beach
8 studies recruiting.
San Francisco
8 studies recruiting.
Walnut Creek
7 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
Alzheimer's Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections